TrialDrugs in R&D2016

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies.

Paul Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.